Jason Kane Russell

Title(s)Postdoctoral Scholar - Research Associate
SchoolKeck School of Medicine of Usc
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Neuropsychiatric Symptom Emergence in Down Syndrome-Associated Alzheimer's Disease is Associated With Tau but not Amyloid Accumulation. Am J Geriatr Psychiatry. 2026 Sep 25. Russell JK, Newhouse PA, Rafii MS, Wilson JE, Alzheimer’s Biomarker Consortium – Down Syndrome. PMID: 42919767.
      View in: PubMed   Mentions:
    2. Facial feature removal in magnetic resonance imaging scans of adults with Down syndrome: A de-facing methodological study. Alzheimers Dement. 2026 Jul; 22(7):e71614. Russell JK, Rafii MS, Kremers WK, Przybelski SA, Vemuri P, Petersen RC, Graff-Radford J, Jack CR, Schwarz CG. PMID: 42360128; PMCID: PMC13307342.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome. JAMA Neurol. 2026 Mar 01; 83(3):294-296. Russell JK, Schlachetzki Z, Ances BM, Rafii MS, Alzheimer’s Biomarker Consortium–Down Syndrome Study. PMID: 41525055; PMCID: PMC12797125.
      View in: PubMed   Mentions:    Fields:    
    4. Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population. Curr Opin Neurol. 2026 Apr 01; 39(2):210-216. Russell JK, Schlachetzki Z, Rafii MS. PMID: 41709686.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Relationship of cholinergic basal forebrain atrophy with the time course of Alzheimer's disease pathology and cognitive decline in adults with Down syndrome: a longitudinal cohort study. Alzheimers Dement. 2026 01; 22(1):e71028. Russell JK, Schlachetzki Z, Conley AC, Boyd BD, Newhouse PA, Aisen PS, Rafii MS, Alzheimer's Biomarker Consortium on Down Syndrome Study. PMID: 41521149; PMCID: PMC12790954.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants. Alzheimers Res Ther. 2025 07 01; 17(1):144. Conley AC, Key AP, Blackford JU, Russell JK, Albert KM, Gong X, Bubser M, Rook JM, Conn PJ, Lindsley CW, Jones CK, Newhouse PA. PMID: 40598606; PMCID: PMC12211128.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    7. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's disease: A Single Ascending-Dose Study in Healthy Participants. Res Sq. 2025 Apr 04. Conley AC, Key AP, Blackford JU, Russell JK, Albert KM, Gong X, Bubser M, Rook JM, Conn PJ, Lindsley CW, Jones CK, Newhouse PA. PMID: 40235479; PMCID: PMC11998771.
      View in: PubMed   Mentions:
    8. Brain cholinergic terminal density utilizing [18F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performance. Alzheimers Dement. 2025 04; 21(4):e70134. Russell JK, Conley AC, Boyd BD, Begnoche JP, Schlossberg R, Stranick A, Rosenberg AJ, Acosta LMY, Martin D, Neal Y, Rafii MS, Dumas J, Newhouse PA. PMID: 40189807; PMCID: PMC11972980.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Resistance and resilience to Alzheimer's disease in Down syndrome. Alzheimers Dement. 2025 04; 21(4):e70151. Boyle R, Koops EA, Ances B, Andrews EJ, Arenaza-Urquijo EM, Bejanin A, Brickman AM, Buckley RF, Clas GS, Costello E, Coughlan GT, Conley AC, Deng F, de Paula Faria D, Edwards N, Flores-Aguilar L, Fortea J, Ghazi Saidi L, Head E, Hom CL, Koenig K, Lao P, Lengyel I, Li YJ, Loi S, Loughrey D, McGlinchey E, Newhouse P, Pertierra L, Prokopiou PC, Qi Q, de Paula França Resende E, Russell J, Scanlon CE, Schneider C, Schultz SA, Seto M, Shaka S, Soldan A, Vaqué Alcázar L, Weng Y, Wilson JE, Zaman SH, Zsadányi SE, Hartley S. PMID: 40289889; PMCID: PMC12035553.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    10. The Role of Estrogen in Brain and Cognitive Aging. Neurotherapeutics. 2019 07; 16(3):649-665. Russell JK, Jones CK, Newhouse PA. PMID: 31364065; PMCID: PMC6694379.
      View in: PubMed   Mentions: 137     Fields:    Translation:HumansAnimals
    Jason's Networks
    Concepts (44)
    Derived automatically from this person's publications.
    _
    Co-Authors (6)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _